Squar Milner Financial Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Squar Milner Financial Services’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-529	Closed	-$40K	–	738
2020 Q1	$40K	Hold	529	–	–	0.02%	384
2019 Q4	$50K	Buy	+529	New	+$45.8K	0.03%	407
2019 Q3	–	Sell	-529	Closed	-$46K	–	732
2019 Q2	$46K	Hold	529	–	–	0.03%	363
2019 Q1	$47K	Hold	529	–	–	0.03%	326
2018 Q4	$38K	Buy	529 +399	+307%	+$32.1K	0.04%	322
2018 Q3	$12K	Sell	130 -1,335	-91%	-$129K	0.01%	471
2018 Q2	$139K	Buy	+1,465	New	+$135K	0.12%	206

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Squar Milner Financial Services's XBI Position: Q2 2020 in Review

Squar Milner Financial Services sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2020, closing a stake of 529 shares — an estimated $40K sold.

Squar Milner Financial Services first reported a position in XBI in Q2 2018 and held it in 7 quarters. The position peaked at $139K in Q2 2018. 525 funds tracked by Wall St. Rank hold XBI as of Q2 2020.

Squar Milner Financial Services reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2020 after selling out during the quarter.
Squar Milner Financial Services sold 529 State Street SPDR S&P Biotech ETF shares in Q2 2020, an estimated $40K.
Squar Milner Financial Services first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and held it in 7 quarters.
Squar Milner Financial Services's State Street SPDR S&P Biotech ETF position peaked at $139K in Q2 2018.
525 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2020.

Based on Squar Milner Financial Services's 13F filing for Q2 2020, filed 16 Jul 2020.